NO981719L - Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b - Google Patents

Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b

Info

Publication number
NO981719L
NO981719L NO981719A NO981719A NO981719L NO 981719 L NO981719 L NO 981719L NO 981719 A NO981719 A NO 981719A NO 981719 A NO981719 A NO 981719A NO 981719 L NO981719 L NO 981719L
Authority
NO
Norway
Prior art keywords
protein
medications
containing protein
medicines
survival
Prior art date
Application number
NO981719A
Other languages
English (en)
Norwegian (no)
Other versions
NO981719D0 (no
Inventor
Kenneth G Haglid
Original Assignee
A & Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A & Science Invest Ab filed Critical A & Science Invest Ab
Publication of NO981719D0 publication Critical patent/NO981719D0/no
Publication of NO981719L publication Critical patent/NO981719L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO981719A 1995-10-17 1998-04-16 Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b NO981719L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9503620A SE505316C2 (sv) 1995-10-17 1995-10-17 Användning av proteinet S-100b för framställning av läkemedel för nervceller
PCT/SE1996/001305 WO1997014427A1 (en) 1995-10-17 1996-10-15 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b

Publications (2)

Publication Number Publication Date
NO981719D0 NO981719D0 (no) 1998-04-16
NO981719L true NO981719L (no) 1998-06-16

Family

ID=20399846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981719A NO981719L (no) 1995-10-17 1998-04-16 Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b

Country Status (11)

Country Link
US (1) US5990080A (et)
EP (1) EP0952844A1 (et)
JP (1) JPH11515003A (et)
AU (1) AU713332B2 (et)
CA (1) CA2235278A1 (et)
CZ (1) CZ116698A3 (et)
EE (1) EE9800108A (et)
NO (1) NO981719L (et)
NZ (1) NZ320721A (et)
SE (1) SE505316C2 (et)
WO (1) WO1997014427A1 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258776B1 (en) * 1997-08-12 2001-07-10 Novartis Ag Calcium-regulated kinase
US20020072493A1 (en) 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
US20030108528A1 (en) * 1998-05-19 2003-06-12 Michal Eisenbach-Schwartz Activated t-cells, nervous system-specific antigens and their uses
CA2328612A1 (en) * 1998-05-19 1999-11-25 Yeda Research And Development Co., Ltd. Activated t cells, nervous system-specific antigens and their uses
DE19915485A1 (de) * 1999-04-07 2000-10-19 Hugo A Katus Therapie der Herzinsuffizienz
WO2003047500A2 (en) 2001-12-06 2003-06-12 Yeda Research And Development Co. Ltd Vaccine and method for treatment of motor neurone diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9164591A (en) * 1990-12-14 1992-07-08 New York University Functional interactions between glial s-100b and central nervous system serotonergic neurons

Also Published As

Publication number Publication date
JPH11515003A (ja) 1999-12-21
EP0952844A1 (en) 1999-11-03
US5990080A (en) 1999-11-23
CA2235278A1 (en) 1997-04-24
AU7352396A (en) 1997-05-07
EE9800108A (et) 1998-10-15
CZ116698A3 (cs) 1998-09-16
WO1997014427A1 (en) 1997-04-24
NZ320721A (en) 2000-07-28
SE505316C2 (sv) 1997-08-04
SE9503620D0 (sv) 1995-10-17
NO981719D0 (no) 1998-04-16
SE9503620L (sv) 1997-04-18
AU713332B2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
DE69113470D1 (de) Intraokulares und intraorbitales Implantat zur kontrollierten Zuführung von Arzneimitteln.
DE69100282T2 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
ATE241394T1 (de) Beigeordnetes polymersystem zur verwendung mit einer medizinischen vorrichtung
DE59610355D1 (de) Medizinisches implantat
PT703786E (pt) Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
DK0830377T3 (da) Glucagon-lignende peptid-2 og dets terapeutiske anvendelse
FI952701A0 (fi) Metallisen kirurgisen istukkaan käsittelymenetelmä
ATE207743T1 (de) Pharmazeutische präparate zur gezielten behandlung von morbus crohn und colitis ulcerosa
DE69600983D1 (de) Kapselpräparate zur Behandlung von Pflanzen
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
NO981719L (no) Anvendelse av protein S-100b i medisiner og medisiner inneholdende protein S-100b
ATE261737T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
DE3866045D1 (de) Arzneimittel zur behandlung von uraemie.
DE58903306D1 (de) Arzneimittel enthaltend aminoacridine zur iontophoretischen behandlung von carcinomen.
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
GB9505082D0 (en) Medicament
SE9000207D0 (sv) Laekemedel samt anvaendningen av detsamma
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NZ502022A (en) Shaped products for medical purposes formed from coral of species Acropora
ATE147988T1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
NO933628L (no) Fremgangsmaate og blanding for behandling av Herpes-infeksjoner
DE19775036I2 (de) Arzneimittel zur Behandlung von Augenentzündung.
RU98109592A (ru) Применение белка s-100b в лекарственных средствах и лекарственные средства, содержащие белок s-100b
SE9002274D0 (sv) Novel 3,3'-dithiobis(propionic esters).

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application